Rheumatoid arthritis C. treatment and assessments

Alyce M. Oliver, E. William St. Clair

Research output: Chapter in Book/Report/Conference proceedingChapter

7 Citations (Scopus)

Abstract

The assessment of RA demands a careful history and examination, with a detailed joint count to determine disease activity. The level of clinical disease activity largely determines the need for therapy. DMARDs are central to the control of disease activity and resulting joint damage. The availability of an expanding array of DMARDs and biologics has created new opportunities to effectively intervene in this condition. The standard of care for RA continues to evolve with increasing evidence that persistent joint inflammation leads to irreversible damage and disability. As a result, combination DMARD regimens are being employed to afford optimal disease control in order to avert permanent joint injury.

Original languageEnglish (US)
Title of host publicationPrimer on the Rheumatic Diseases
Subtitle of host publicationThirteenth Edition
PublisherSpringer New York
Pages133-141
Number of pages9
ISBN (Print)9780387356648
DOIs
StatePublished - Dec 1 2008
Externally publishedYes

Fingerprint

Antirheumatic Agents
Rheumatoid Arthritis
Joints
Standard of Care
Biological Products
History
Inflammation
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Oliver, A. M., & St. Clair, E. W. (2008). Rheumatoid arthritis C. treatment and assessments. In Primer on the Rheumatic Diseases: Thirteenth Edition (pp. 133-141). Springer New York. https://doi.org/10.1007/978-0-387-68566-3_6

Rheumatoid arthritis C. treatment and assessments. / Oliver, Alyce M.; St. Clair, E. William.

Primer on the Rheumatic Diseases: Thirteenth Edition. Springer New York, 2008. p. 133-141.

Research output: Chapter in Book/Report/Conference proceedingChapter

Oliver, AM & St. Clair, EW 2008, Rheumatoid arthritis C. treatment and assessments. in Primer on the Rheumatic Diseases: Thirteenth Edition. Springer New York, pp. 133-141. https://doi.org/10.1007/978-0-387-68566-3_6
Oliver AM, St. Clair EW. Rheumatoid arthritis C. treatment and assessments. In Primer on the Rheumatic Diseases: Thirteenth Edition. Springer New York. 2008. p. 133-141 https://doi.org/10.1007/978-0-387-68566-3_6
Oliver, Alyce M. ; St. Clair, E. William. / Rheumatoid arthritis C. treatment and assessments. Primer on the Rheumatic Diseases: Thirteenth Edition. Springer New York, 2008. pp. 133-141
@inbook{19adcc8e80054a2185fa3c912cfdd6ec,
title = "Rheumatoid arthritis C. treatment and assessments",
abstract = "The assessment of RA demands a careful history and examination, with a detailed joint count to determine disease activity. The level of clinical disease activity largely determines the need for therapy. DMARDs are central to the control of disease activity and resulting joint damage. The availability of an expanding array of DMARDs and biologics has created new opportunities to effectively intervene in this condition. The standard of care for RA continues to evolve with increasing evidence that persistent joint inflammation leads to irreversible damage and disability. As a result, combination DMARD regimens are being employed to afford optimal disease control in order to avert permanent joint injury.",
author = "Oliver, {Alyce M.} and {St. Clair}, {E. William}",
year = "2008",
month = "12",
day = "1",
doi = "10.1007/978-0-387-68566-3_6",
language = "English (US)",
isbn = "9780387356648",
pages = "133--141",
booktitle = "Primer on the Rheumatic Diseases",
publisher = "Springer New York",
address = "United States",

}

TY - CHAP

T1 - Rheumatoid arthritis C. treatment and assessments

AU - Oliver, Alyce M.

AU - St. Clair, E. William

PY - 2008/12/1

Y1 - 2008/12/1

N2 - The assessment of RA demands a careful history and examination, with a detailed joint count to determine disease activity. The level of clinical disease activity largely determines the need for therapy. DMARDs are central to the control of disease activity and resulting joint damage. The availability of an expanding array of DMARDs and biologics has created new opportunities to effectively intervene in this condition. The standard of care for RA continues to evolve with increasing evidence that persistent joint inflammation leads to irreversible damage and disability. As a result, combination DMARD regimens are being employed to afford optimal disease control in order to avert permanent joint injury.

AB - The assessment of RA demands a careful history and examination, with a detailed joint count to determine disease activity. The level of clinical disease activity largely determines the need for therapy. DMARDs are central to the control of disease activity and resulting joint damage. The availability of an expanding array of DMARDs and biologics has created new opportunities to effectively intervene in this condition. The standard of care for RA continues to evolve with increasing evidence that persistent joint inflammation leads to irreversible damage and disability. As a result, combination DMARD regimens are being employed to afford optimal disease control in order to avert permanent joint injury.

UR - http://www.scopus.com/inward/record.url?scp=84892250631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892250631&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-68566-3_6

DO - 10.1007/978-0-387-68566-3_6

M3 - Chapter

AN - SCOPUS:84892250631

SN - 9780387356648

SP - 133

EP - 141

BT - Primer on the Rheumatic Diseases

PB - Springer New York

ER -